Holen Sie sich die Stockscreener-App
3.25
7.97%
0.24
Vorhandelsmarkt:
3.21
-0.04
-1.23%
Schlusskurs vom Vortag:
$3.01
Offen:
$2.93
24-Stunden-Volumen:
220.61K
Relative Volume:
0.96
Marktkapitalisierung:
$33.84M
Einnahmen:
$114.70K
Nettoeinkommen (Verlust:
$-37.06M
KGV:
-0.8139
EPS:
-3.9929
Netto-Cashflow:
$-30.69M
1W Leistung:
+7.26%
1M Leistung:
+61.69%
6M Leistung:
+91.18%
1J Leistung:
-0.31%
1-Tages-Spanne:
$2.93
$3.33
1-Wochen-Bereich:
$2.9001
$3.33
52-Wochen-Spanne:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
Sab Biotherapeutics Inc
Sektor
Branche
Telefon
305-845-2813
Adresse
777 W 41ST ST, MIAMI BEACH
Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
3.25 | 31.34M | 114.70K | -37.06M | -30.69M | -3.9929 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
Why retail investors pile into SAB Biotherapeutics Inc. stockJuly 2025 Final Week & Capital Protection Trading Alerts - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant reversing from oversold territoryPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-03 02:45:13 - newser.com
Published on: 2025-11-03 01:49:06 - newser.com
Quantitative breakdown of SAB Biotherapeutics Inc. Equity Warrant recent moveTrade Volume Summary & Growth Focused Stock Reports - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains on buy listsQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains undervaluedWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Published on: 2025-11-02 20:28:45 - newser.com
Will SAB Biotherapeutics Inc. rebound enough to break evenPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What analysts say about SAB Biotherapeutics Inc stockFlag and Pennant Patterns & Free Daily Stock Hotspot Analysis - earlytimes.in
Using data filters to optimize entry into SAB Biotherapeutics Inc. Equity WarrantLong Setup & Real-Time Buy Signal Notifications - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock keep outperforming rivalsCPI Data & Stock Portfolio Risk Management - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant a candidate for recovery play2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
What hedge fund activity signals for SAB Biotherapeutics Inc. stockShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock benefits from global expansionWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
Will SAB Biotherapeutics Inc. stock maintain dividend yield2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Ranking SAB Biotherapeutics Inc. Equity Warrant among high performing stocks via toolsMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Trend analysis for SAB Biotherapeutics Inc. Equity Warrant this weekWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
What insider trading reveals about SAB Biotherapeutics Inc. Equity Warrant stockJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc. Equity WarrantMarket Performance Report & Free Accurate Trade Setup Notifications - newser.com
Is SAB Biotherapeutics Inc. forming a reversal patternStop Loss & Accurate Trade Setup Notifications - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc.Quarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Will SAB Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Decliners & Stepwise Swing Trade Plans - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from sector rotation2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock performs in interest rate cyclesJuly 2025 Update & AI Driven Stock Reports - newser.com
Published on: 2025-11-01 03:46:19 - newser.com
Tick level data insight on SAB Biotherapeutics Inc. volatilityQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com
How to build a custom watchlist for SAB Biotherapeutics Inc. Equity WarrantWeekly Volume Report & AI Driven Price Forecasts - newser.com
Will SAB Biotherapeutics Inc. stock see PE expansionWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Using Python tools to backtest SAB Biotherapeutics Inc. Equity Warrant strategiesJuly 2025 Levels & Weekly High Return Opportunities - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock deliver surprise earnings beatJuly 2025 Retail & Safe Capital Preservation Plans - newser.com
Real time pattern detection on SAB Biotherapeutics Inc. Equity Warrant stockTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sab Biotherapeutics Inc-Aktie (SABS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director |
Sep 29 '25 |
Option Exercise |
1.75 |
1,740,000 |
3,045,000 |
2,198,457 |
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):